These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Dementia: role of imaging]. Meder JF; Henry-Feugeas MC; Oppenheim C; Naggara O; Frédy D J Radiol; 2003 Nov; 84(11 Pt 2):1819-28. PubMed ID: 14739838 [TBL] [Abstract][Full Text] [Related]
27. ["Red flags": when to be alerted and how to explore?]. Tison F Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230 [TBL] [Abstract][Full Text] [Related]
28. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia. Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904 [TBL] [Abstract][Full Text] [Related]
29. Structural magnetic resonance imaging in frontotemporal lobar dementia. Bertrand A; Stroër S; Le Ber I; Teichmann M; Dormont D Geriatr Psychol Neuropsychiatr Vieil; 2017 Sep; 15(3):285-294. PubMed ID: 28872040 [TBL] [Abstract][Full Text] [Related]
30. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice. Atri A Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453 [TBL] [Abstract][Full Text] [Related]
33. Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy. Tse NY; Chen Y; Irish M; Cordato NJ; Landin-Romero R; Hodges JR; Piguet O; Ahmed RM Brain Commun; 2020; 2(2):fcaa194. PubMed ID: 33381758 [TBL] [Abstract][Full Text] [Related]
34. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
35. Detecting frontotemporal dementia syndromes using MRI biomarkers. Bruun M; Koikkalainen J; Rhodius-Meester HFM; Baroni M; Gjerum L; van Gils M; Soininen H; Remes AM; Hartikainen P; Waldemar G; Mecocci P; Barkhof F; Pijnenburg Y; van der Flier WM; Hasselbalch SG; Lötjönen J; Frederiksen KS Neuroimage Clin; 2019; 22():101711. PubMed ID: 30743135 [TBL] [Abstract][Full Text] [Related]
36. [Neuroepigenetics: Desoxyribonucleic acid methylation in Alzheimer's disease and other dementias]. Mendioroz Iriarte M; Pulido Fontes L; Méndez-López I Med Clin (Barc); 2015 May; 144(10):457-64. PubMed ID: 24907105 [TBL] [Abstract][Full Text] [Related]
37. MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism. Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stamboulis E; Kapaki E AJNR Am J Neuroradiol; 2018 Jun; 39(6):1047-1051. PubMed ID: 29622555 [TBL] [Abstract][Full Text] [Related]
38. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815 [TBL] [Abstract][Full Text] [Related]
39. Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease. Wiltshire K; Foster S; Kaye JA; Small BJ; Camicioli R Dement Geriatr Cogn Disord; 2005; 20(6):345-51. PubMed ID: 16192724 [TBL] [Abstract][Full Text] [Related]